{{Rsnum
|rsid=659366
|Gene=UCP2
|Chromosome=11
|position=73983709
|Orientation=plus
|GMAF=0.4155
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=UCP2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 41.6 | 43.4 | 15.0
| HCB | 32.6 | 43.7 | 23.7
| JPT | 19.5 | 49.6 | 31.0
| YRI | 29.3 | 48.3 | 22.4
| ASW | 36.8 | 42.1 | 21.1
| CHB | 32.6 | 43.7 | 23.7
| CHD | 29.4 | 54.1 | 16.5
| GIH | 44.4 | 45.5 | 10.1
| LWK | 31.2 | 59.6 | 9.2
| MEX | 31.6 | 49.1 | 19.3
| MKK | 31.0 | 54.2 | 14.8
| TSI | 45.5 | 45.5 | 8.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19387457
|Title=Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases
}}

{{omim
|id=601693
|desc=UNCOUPLING PROTEIN 2; UCP2
|rsnum=659366
}}
{{PMID Auto
|PMID=19769793
|Title=Variation in the UCP2 and UCP3 genes associates with abdominal obesity and serum lipids: The Finnish Diabetes Prevention Study
|OA=1
}}

{{omim
|id=601693
|rsnum=659366
|variant=0001
}}

{{PMID Auto
|PMID=21883184
|Title=Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population
}}

{{PMID Auto
|PMID=22241057
|Title=Variation in The Uncoupling Protein 2 and 3 Genes and Human Performance
|OA=1
}}

{{PMID|16046815|OA=1
}} Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes.

{{PMID|17570749|OA=1
}} Genetic prediction of future type 2 diabetes.

{{PMID|17701054}} Interaction between the UCP2-866G/A, mtDNA 10398G/A and PGC1alpha p.Thr394Thr and p.Gly482Ser polymorphisms in type 2 diabetes susceptibility in North Indian population.

{{PMID|17870627}} Association between obesity and insulin resistance with UCP2-UCP3 gene variants in Spanish children and adolescents.

{{PMID|19406964|OA=1
}} Association of genetic variants with chronic kidney disease in Japanese individuals.

{{PMID|19681913}} Polymorphisms of the UCP2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus.

{{PMID|20145583|OA=1
}} Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.

{{PMID|20359253}} Effect of the common -866G/A polymorphism of the uncoupling protein 2 gene on weight loss and body composition under sibutramine therapy in an obese Taiwanese population.

{{PMID|22349573}} The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.

{{PMID Auto
|PMID=22533685
|Title=Uncoupling protein 2 gene polymorphisms are associated with obesity
|OA=1
}}

{{PMID Auto
|PMID=23639961
|Title=Uncoupling protein 2 -866G/A and uncoupling protein 3 -55C/T polymorphisms in young South African Indian coronary artery disease patients
}}

{{PMID Auto
|PMID=23826253
|Title=Gene Polymorphisms of ADIPOQ +45T&gt;G, UCP2 -866G&gt;A, and FABP2 Ala54Thr on the Risk of Colorectal Cancer: A Matched Case-Control Study
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}